← All trials
NCT04691141
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2021
- Primary completion
- Dec 7, 2023
- Completion date
- Mar 16, 2024
- First posted
- Dec 31, 2020
- Last posted
- Jun 7, 2021
- Enrollment
- 59
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Antengene CorporationLead sponsor
- Tianjin blood research instituteOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.